Cancer Biology & Medicine

Journal Introduction

The predecessor of Cancer Biology & Medicine (CBM) was the Chinese Journal of Clinical Oncology (English version of "Chinese Oncology") founded by Academician Hao Xishan. It was renamed in 2012 and included in SCI in 2017, but all articles since 2012 are available Search in the WOS database. Hosted by the Chinese Association for Science and Technology, the Chinese Anti-Cancer Association and Tianjin Medical University Cancer Hospital. CBM is a golden open access journal, and all published articles can be downloaded on the website.

The uniqueness of this journal is that it has gone out of independence and entered the SCI road without the help of any international publishers.

Scope of publication

Cancer Biology & Medicine reports on the frontiers and latest research results of international oncology, with special attention to basic research and clinical translational treatment of domestic oncology diseases, mainly covering the following topics:

Cancer genetics

Cancer and stem call biology

Molecular and clinical immunology

Cancer prevention and epidemiology

Cancer biomarkers

Radiation oncology

Oncology clinical trials

Mechanisms of drug sensitivity and resistance

Targeted therapy and immunotherapy

Multidisciplinary treatment and personalized medicine

Type of Post

Original Article, Editorial, Review, Minireview, Letter to the Editor, Practice Guideline, Faculty 1000 Spotlight, Perspective, MDT Case Study, Guideline Interpretation